Convalescent Plasma News and Research

RSS
Immunosuppression in COVID-19 promotes emergence of multiple immune escape mutants

Immunosuppression in COVID-19 promotes emergence of multiple immune escape mutants

Large-scale study focuses on COVID-19 antibodies in asymptomatic and symptomatic patients

Large-scale study focuses on COVID-19 antibodies in asymptomatic and symptomatic patients

About 84% of antibodies in plasma target non-RBD epitopes on SARS-CoV-2 spike protein, finds study

About 84% of antibodies in plasma target non-RBD epitopes on SARS-CoV-2 spike protein, finds study

UT Southwestern reports first cases of Brazilian variant of COVID-19 infection in North Texas

UT Southwestern reports first cases of Brazilian variant of COVID-19 infection in North Texas

Real-world study in India finds COVISHIELD vaccine safe and effective

Real-world study in India finds COVISHIELD vaccine safe and effective

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

Immune escape by SARS-CoV-2 mutations acquired in mink

Immune escape by SARS-CoV-2 mutations acquired in mink

Chronic SARS-CoV-2 infections favor viral adaptation, says study

Chronic SARS-CoV-2 infections favor viral adaptation, says study

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed

Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed

Studies provide insights into characteristics and clinical effect of SARS-CoV-2 B.1.1.7 variant

Studies provide insights into characteristics and clinical effect of SARS-CoV-2 B.1.1.7 variant

Novel polyclonal antibody XAV-19 efficiently neutralizes UK and South African SARS-CoV-2 variants

Novel polyclonal antibody XAV-19 efficiently neutralizes UK and South African SARS-CoV-2 variants

South African and Brazilian SARS-CoV-2 variants can evade antibodies from therapies, vaccines, and infection

South African and Brazilian SARS-CoV-2 variants can evade antibodies from therapies, vaccines, and infection

70% of SARS-CoV-2 infected in Wuhan still have IgG antibodies

70% of SARS-CoV-2 infected in Wuhan still have IgG antibodies

Study finds CD8+ T cell responses detect all major SARS-CoV-2 variants

Study finds CD8+ T cell responses detect all major SARS-CoV-2 variants

Antibodies produced from infection with SARS-CoV-2 501Y.V2 protect against other variants

Antibodies produced from infection with SARS-CoV-2 501Y.V2 protect against other variants

Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay

Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay

Have scientists found SARS-CoV-2's Achilles' heel?

Have scientists found SARS-CoV-2's Achilles' heel?

Scientists seek Covid treatment answers in cheap, older drugs

Scientists seek Covid treatment answers in cheap, older drugs

mRNA vaccines and monoclonal antibodies protect against new NYC-B.1.526 variant

mRNA vaccines and monoclonal antibodies protect against new NYC-B.1.526 variant